Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Peter van de Kerkhof Headshot

Peter

van de Kerkhof

,

MD, PhD

Chief Medical Officer
International Psoriasis Council
Eefde
,
Netherlands
IPC Chief Medical Officer
Professor Peter van de Kerkhof served as head of the Department of Dermatology at the Radboud University Nijmegen Medical Centre, The Netherlands, since 1992 and is currently a Professor Emeritus there. He graduated in medicine from the Catholic University of Nijmegen in 1978 and trained in dermatology at the St. Radboud Hospital, Nijmegen. In 1983 and in 1990 he completed his theses in the faculty of medicine and faculty of sciences resp. Between 1980 and 1984 he completed his training as a dermatologist. Research interests of Professor van de Kerkhof are psoriasis, disorders of keratinization, inflammation and clinical pharmacology of the skin. He has been president of major European Dermatological societies such as the European Society of Dermatological Research and the European Dermatology Forum. He is a member of the editorial board of several international dermatological journals. He is an author or co-author of more than 800 peer-reviewed dermatological journals. He joined the IPC Staff as Chief Medical Officer in July 2018.
Last Updated:
04/24/2025

Areas of Interest

Patient care for patients with complex psoriasis. Clinical research on new treatments and real world evidence. Pathogenesis of psoriasis and mode of action of treatments.

IPC Committees / Groups

Telemedicine Working Group

Languages Spoken

Dutch, English, French, German, Italian

Involvement with Other Organization(s)

Member of Advisory board for the International Federation of Psoriasis Associations (IFPA).

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026